Contineum Therapeutics, Inc. ($CTNM)
Lorrain Daniel S. โ Chief Scientific Officer
Shares
100
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 5, 2026
EPS:Est: -0.50
Revenue:Est: $5.00M
Transaction Details
| Insider | Lorrain Daniel S. |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 19, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Shares Purchased | 100 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 75,430 |
| Derivative | Derivative |
| Accession Number | 0001437749-26-004912 |
| Document | View SEC Filing |